Search

Home > BioCentury This Week > Ep. 286 - Sofinnova’s Pan-European Accelerator, China Biotechs, Trump Tariffs
Podcast: BioCentury This Week
Episode:

Ep. 286 - Sofinnova’s Pan-European Accelerator, China Biotechs, Trump Tariffs
Category: Science & Medicine
Duration: 00:24:30
Publish Date: 2025-03-25 01:00:00
Description:

European venture firm Sofinnova Partners is expanding the reach of its Biovelocita accelerator beyond Italy to stretch across the greater continent. On the latest BioCentury This Week podcast, BioCentury’s editors discuss how Biovelocita became the largest life sciences accelerator in Europe. The editors also discuss Novo Nordisk's latest addition to its obesity pipeline via a deal in China, and how the partnership reflects the state of cross-border dealmaking more broadly. And Washington Editor Steve Usdin assesses President Trump’s threat to impose 25% tariffs on pharmaceutical imports and provides an update on how FDA’s staff is navigating the policies of the new administration.

View full story: https://www.biocentury.com/article/655438

00:00 - Introduction
02:25 - Sofinnova’s Pan-European Accelerator
08:27 - China Biotechs
14:59 - Trump Tariffs

To submit a question to BioCentury’s editors, email the BioCentury This Week team at podcasts@biocentury.com.

Reach us by sending a text
Total Play: 0